Results 171 to 180 of about 950,583 (268)

Internet-guided HCV-RNA testing: A promising tool to achieve hepatitis C micro-elimination among men who have sex with men. [PDF]

open access: yesJ Viral Hepat, 2022
Prinsenberg T   +5 more
europepmc   +1 more source

Therapeutic and Prophylactic Agents for Viral Diseases: Current Status, Challenges, and Future Prospects

open access: yesMedComm, Volume 7, Issue 11, November 2026.
This review summarizes current therapeutic and prophylactic strategies for global viral diseases, including vaccines, PrEP, direct‐acting antivirals, and emerging modalities such as CRISPR and siRNA. It highlights their clinical impact, ongoing challenges, and future priorities toward broader protection, improved delivery, and more effective antiviral ...
Sawar Khan   +12 more
wiley   +1 more source

Comparıson Of Hcv Rna And Hcv Core Antıgen In Genotype 1 Chronıc Hepatıtıs C Patıents

open access: yes, 2014
Background: Anti-HCV test is currently used in the diagnosis of hepatitis C, while hepatitis C virus ribonucleic acid (HCV RNA) is used in the determination of viral load.
Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü   +6 more
core  

Sex and Etiology Differences in Overall Survival and Adverse Liver Events in Hepatocellular Carcinoma: An International Multicenter Study

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Among 7623 patients with newly diagnosed hepatocellular carcinoma from 41 centers in five countries, women had modestly better overall survival and fewer adverse liver events than men. Alcohol‐related and MASLD‐related disease were associated with higher liver‐event risks than HBV‐related disease.
Feng Xia   +47 more
wiley   +1 more source

Liquid Biopsy: Past, Present, and Future

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Liquid biopsy has expanded from cancer genotyping to a broader strategy for probing both oncologic and nononcologic conditions through circulating analytes and multilayer molecular readouts. This review traces the field's past, present, and future—summarizing where liquid biopsy is most actionable today, why performance varies across contexts, and ...
Jiachen Liu   +8 more
wiley   +1 more source

Resistant-Associated Substitutions Do Not Affect HCV RNA and HCV Core Antigen Clearance During Direct-Acting Antiviral Agent Treatment in a Real-World Setting. [PDF]

open access: yesInfect Drug Resist, 2022
Chen H   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy